Senaste siffrorna, (up to 26/06/2021) , ASTRAZENECA, Biverkningar
EudraVigilance for COVID-19 VACCINE ASTRAZENECA (CHADOX1 NCOV-19) (up to 26/06/2021)
https://dap.ema.europa.eu/analytics/saw.dll?PortalPages&PortalPath=%2Fshared%2FPHV%20D AP%2F_portal%2FDAP&Action=Navigate&P0=1&P1=eq&P2=% 22Line%20Listing%20Objects%22.%22Substance%20High% 20Level%20Code%22&P3=1+42325700
Blood and lymphatic system disorders: 150
Cardiac disorders: 431
Congenital, familial and genetic disorders: 3
Ear and labyrinth disorders 0
Endocrine disorders 3
Eye disorders 14
Gastrointestinal disorders: 169
General disorders and administration site conditions: 952
Hepatobiliary disorders: 29
Immune system disorders: 13
Infections and infestations: 236
Injury, poisoning and procedural complications: 86
Investigations: 85
Metabolism and nutrition disorders: 51
Musculoskeletal and connective tissue disorders: 47
Neoplasms benign, malignant and unspecified (incl cysts and polyps): 8
Nervous system disorders: 573
Pregnancy, puerperium and perinatal conditions: 4
Psychiatric disorders: 29
Renal and urinary disorders: 34
Reproductive system and breast disorders: 0
Respiratory, thoracic and mediastinal disorders: 414
Skin and subcutaneous tissue disorders: 23
Social circumstances: 5
Surgical and medical procedures: 16
Vascular disorders: 258
Totalt: 3633 Döda